Case Name |
Date Filed |
Judge |
Drug |
Patent No(s). |
UroGen Pharma Ltd. v. Teva Pharms., Inc., 24-0417 (D. Del.) |
Apr. 2, 2024 |
Hon. Colm F. Connolly |
Jelmyto® (mitomycin for pyelocalyceal solution) |
9040074
9950069 |
Novartis Pharms. Corp. v. Teva Pharms., Inc., 24-0428 (D. Del.) |
Apr. 4, 2024 |
Hon. Gregory B. Williams |
Tasigna® (nilotinib HCl capsules) |
8,163,904
8,293,756
8,389,537
8,415,363
8,501,760
9,061,029 |
Janssen Pharms., Inc. v. Macleods Pharms., Ltd., 24-4564 (D.N.J.) |
Apr. 4, 2024 |
Hon. Georgette Castner |
Invokamet® (canagliflozin / metformin HCl tablets) |
11,576,894 |
Horizon Therapeutics U.S. Holding LLC v. Teva Pharms., Inc., 24-0432 (D. Del.) |
Apr. 5, 2024 |
Hon. Gregory B. Williams |
Ravicti® (glycerol phenylbutyrate oral liquid) |
8,642,012
9,254,278
9,326,966
9,561,197
9,962,359
9,999,608
10,045,958
10,045,959
10,183,002
10,183,003
10,183,004
10,183,005
10,183,006
10,668,040 |
Actelion Pharms. Ltd. v. Gland Pharma Ltd., 24-0434 (D. Del.) |
Apr. 5, 2024 |
Hon. Jennifer L. Hall |
Veletri® (epoprostenol sodium for injection) |
8,598,227 |
Upsher-Smith Labs., LLC v. AMTA Labs Ltd., 24-0058 (D. Del.) |
Jan. 17, 2024 |
Hon. Gregory B. Williams |
Qudexy® XR (topiramate extended-release capsules) |
10,363,224 |
AbbVie Inc. v. Zydus Pharms. (USA) Inc., 24-4603 (D.N.J.) |
Apr. 5, 2024 |
Hon. Zahid N. Quraishi |
Ubrelvy® (ubrogepant tablets) |
10,117,836
11,717,515
11,857,542
11,925,709 |
Salix Pharms., Inc. v. Amneal Pharms. of NY, LLC, 24-4607 (D.N.J.) |
Apr. 5, 2024 |
Hon. Edward S. Kiel |
Xifaxan® (rifaximin tablets) |
11,779,571
11,564,912
10,456,384
8,193,196
8,518,94
8,741,90
9,271,968
10,703,763 |
Axsome Malta Ltd. v. Alkem Labs. Ltd., 24-4608 (D.N.J.) |
Apr. 5, 2024 |
Hon. Madeline Cox Arleo |
Sunosi® (solriamfetol tablets) |
11,771,666
11,771,667
11,779,554
11,793,776
11,839,598
11,839,599
11,850,226
11,850,227
11,850,228
11,857,528
11,865,098
11,872,203
11,872,204 |
Bausch Health Ireland Ltd. v. Mylan Pharms. Inc., 24-0036 (N.D.W.V.) |
Apr. 5, 2024 |
Hon. Thomas S. Kleeh |
Trulance® (plecanatide tablets) |
11,834,521 |
Chiesi Farmaceutici S.p.A v. Teva Pharms Inc., 24-0441 (D. Del.) |
Apr. 8, 2024 |
Hon. Colm F. Connolly |
Mycapssa® (octreotide delayed-release capsules) |
8,329,198
8,535,695
9,265,812
9,566,246
10,238,709
10,695,397
11,052,126
11,141,457
11,338,011
11,510,963
11,857,595
11,890,316 |
Abbvie Inc. v. MSN Pharms. Inc., 24-4662 (D.N.J.) |
Apr. 8, 2024 |
Hon. Zahid N. Quraishi |
Ubrelvy® (ubrogepant tablets) |
10,117,836
11,717,515
11,857,542
11,925,709 |
Vertex Pharms. Inc. v. Lupin Ltd., 24-0458 (D. Del.) |
Apr. 11, 2024 |
Hon. Richard G. Andrews |
Kalydeco® (ivacaftor granules) |
8,883,206
10,272,046
10,646,481
11,147,770
11,564,916
11,752,106 |
AstraZeneca AB v. Laurus Labs Ltd., 24-0459 (D. Del.) |
Apr. 11, 2024 |
Hon. Richard G. Andrews |
Brilinta® (ticagrelor tablets) |
10,300,065 |
AbbVie Inc. v. Hetero USA Inc., 24-4852 (D.N.J.) |
Apr. 11, 2024 |
Hon. Zahid N. Quraishi |
Ubrelvy® (ubrogepant tablets) |
10,117,836
11,717,515
11,857,542
11,925,709 |
Ipsen Biopharms., Inc. v. Conjupro Biotherapeutics, Inc., 24-4991 (D.N.J.) |
Apr. 15, 2024 |
Hon. Renee Marie Bumb |
Onivyde® (irinotecan liposome injection) |
8,329,213
9,339,49
9,364,473
9,452,162
9,492,442
9,717,724
10,980,795
11,369,597 |
Impax Labs., LLC v. Ascent Pharms. Inc., 24-5299 (D.N.J.) |
Apr. 18, 2024 |
Hon. Karen M. Williams |
Rytary® (carbidopa / levodopa extended-release capsules) |
8,377,474
8,454,998
8,557,283
9,089,607
9,089,608
9,463,246
9,533,04
9,901,640 |
Encube Ethicals Pvt. Ltd. v. Dermavant Sciences GmbH, IPR2024-00834 (PTAB) |
Apr. 23, 2024 |
N/A |
Vtama® (tapinarof topical cream) |
11,590,088 |
Fresenius Kabi USA, LLC v. Accord Healthcare Inc., 24-5674 (D.N.J.) |
Apr. 26, 2024 |
Hon. Susan D. Wigenton |
levothyroxine sodium injection |
10,398,669
11,135,190 |
Merck Sharp & Dohme LLC v. Azurity Pharms., Inc., 24-0545 (D. Del.) |
3-May-24 |
Hon. Richard G. Andrews |
Januvia® (sitagliptin phosphate oral solution) |
7,326,708 |
Viiv Healthcare Co. v. Hetero USA, Inc., 24-0547 (D. Del.) |
3-May-24 |
Hon. Mitchell S. Goldberg |
Tivicay® (dolutegravir sodium tablets) |
9,242,986 |
Mitsubishi Tanabe Pharma Corp. v. Apotex Inc., 24-0549 (D. Del.) |
3-May-24 |
Hon. Jennifer L. Hall |
Radicava ORS® (edaravone oral suspension) |
10,987,341
11,241,416
11,478,450
11,826,352 |
Eli Lilly & Co. v. Qilu Pharm. Co., Ltd., 24-5847 (D.N.J.) |
3-May-24 |
Hon. Evelyn Padin |
Reyvow® (lasmiditan tablets) |
11,053,214 |
AstraZeneca AB v. Apotex Inc., 24-0551 (D. Del.) |
6-May-24 |
Hon. Richard G. Andrews |
Xigduo XR® (dapagliflozin / metformin HCl extended-release tablets) |
7,919,598
8,501,698
8,685,934
9,616,028 |
Teva Branded Pharm. Products R&D, Inc. v. Cipla USA, Inc., 24-5856 (D.N.J.) |
6-May-24 |
Hon. Stanley R. Chesler |
QVAR RediHaler® (beclomethasone dipropionate inhalation aerosol) |
11,793,953
11,865,247
11,896,759 |
AstraZeneca Pharms. LP v. Natco Pharma Ltd., 24-5887 (D.N.J.) |
7-May-24 |
Hon. Robert Kirsch |
Lynparza® (olaparib tablets) |
11,970,530
11,975,001 |
AstraZeneca Pharms. LP v. Sandoz Inc., 24-5889 (D.N.J.) |
7-May-24 |
Hon. Robert Kirsch |
Lynparza® (olaparib tablets) |
11,970,530
11,975,001 |
Neurelis, Inc. v. Padagis LLC, 24-0562 (D. Del.) |
8-May-24 |
Hon. Maryellen Noreika |
Valtoco® (diazepam nasal spray) |
8,895,546
11,241,414
11,793,786 |
Esperion Therapeutics, Inc. v. Micro Labs USA, Inc., 24-5921 (D.N.J.) |
8-May-24 |
Hon. Julien Xavier Neals |
Nexletol® (bempedoic acid tablets) |
11,760,714
11,613,511 |
Exelixis, Inc. v. Cipla, Ltd., 24-0565 (D. Del.) |
9-May-24 |
Hon. Richard G. Andrews |
Cabometyx® (cabozantinib (S)-malate tablets) |
8,877,776
11,091,439
11,091,440
11,098,015
11,298,349 |
Breckenridge Pharm., Inc. v. Hetero USA Inc., 24-0571 (D. Del.) |
10-May-24 |
Hon. Gregory B. Williams |
Pradaxa® (dabigatran etexilate mesylate capsules) |
11,013,729
11,752,142 |
Esperion Therapeutics, Inc. v. Renata Ltd., 24-6017 (D.N.J.) |
10-May-24 |
Hon. Julien Xavier Neals |
Nexletol® (bempedoic acid tablets) |
11,760,714
11,613,511 |
Apotex Inc. v. Boehringer Ingelheim Pharms. Inc., 24-0577 (D. Del.) |
13-May-24 |
Hon. Maryellen Noreika |
Ofev® (nintedanib esylate capsules) |
9,907,756
10,105,323 |
Grünenthal GmbH v. Teva Pharms., Inc., 24-6104 (D.N.J.) |
13-May-24 |
Hon. Stanley R. Chesler |
Nucynta® ER (tapentadol HCl extended-release tablets) |
11,344,512 |
Acerta Pharma B.V. v. Cipla Ltd., 24-0587 (D. Del.) |
16-May-24 |
Hon. Gregory B. Williams |
Calquence® (acalabrutinib tablets) |
10,272,083
11,059,829 |
Bayer Intellectual Property GmbH v. Ascent Pharms. Inc., 24-0588 (D. Del.) |
16-May-24 |
Hon. Richard G. Andrews |
Xarelto® (rivaroxaban tablets) |
9,539,218
10,828,310 |
Esperion Therapeutics, Inc. v. Accord Healthcare Inc., 24-6224 (D.N.J.) |
16-May-24 |
Hon. Julien Xavier Neals |
Nexletol® (bempedoic acid tablets) |
11,760,714
11,613,511
11,926,584 |
Esperion Therapeutics, Inc. v. Alkem Labs. Ltd., 24-6263 (D.N.J.) |
17-May-24 |
Hon. Julien Xavier Neals |
Nexletol® (bempedoic acid tablets) Nexlizet® (bempedoic acid / ezetimibe tablets) |
11,760,714
11,613,511
10,912,751
11,744,816 |
Pacira Pharms., Inc. v. eVenus Pharms. Labs. Inc., 24-6294 (D.N.J.) |
20-May-24 |
Hon. Madeline Cox Arleo |
Exparel® (bupivacaine liposome injectable suspension) |
11,819,574
11,819,575 |
Melinta Therapeutics, LLC v. Nexus Pharms., Inc., 24-4180 (N.D. Ill.) |
21-May-24 |
Hon. John F. Kness |
Minocin® (minocycline for injection) |
11,944,634 |
Purdue Pharma L.P. v. Accord Healthcare Inc., 24-0284 (E.D.N.C.) |
21-May-24 |
Hon. Louise Wood Flanagan |
OxyContin® (oxycodone HCl extended-release tablets) |
11,826,472
11,904,055
11,938,225
11,964,056 |
Esperion Therapeutics, Inc. v. Aurobindo Pharma Ltd., 24-6348 (D.N.J.) |
22-May-24 |
Hon. Julien Xavier Neals |
Nexletol® (bempedoic acid tablets) |
11,760,714
11,613,511 |
Pfizer Inc. v. Apotex Inc., 24-0621 (D. Del.) |
23-May-24 |
Hon. Colm F. Connolly |
Nurtec ODT® (rimegepant sulfate tablets) |
8,314,117
8,759,372
11,083,724 |
Pfizer Inc. v. Aurobindo Pharma Ltd., 24-0622 (D. Del.) |
23-May-24 |
Hon. Colm F. Connolly |
Nurtec ODT® (rimegepant sulfate tablets) |
11,083,724 |
Pfizer Inc. v. Changzhou Pharm. Factory, 24-0623 (D. Del.) |
23-May-24 |
Hon. Colm F. Connolly |
Nurtec ODT® (rimegepant sulfate tablets) |
8,314,117
8,759,372
11,083,724 |
Pfizer Inc. v. MSN Labs. Private Ltd., 24-0624 (D. Del.) |
23-May-24 |
Hon. Colm F. Connolly |
Nurtec ODT® (rimegepant sulfate tablets) |
11,083,724 |
Pfizer Inc. v. Natco Pharma Ltd., 24-0625 (D. Del.) |
23-May-24 |
Hon. Colm F. Connolly |
Nurtec ODT® (rimegepant sulfate tablets) |
11,083,724 |
Pfizer Inc. v. Rubicon Research Private Ltd., 24-0626 (D. Del.) |
23-May-24 |
Hon. Colm F. Connolly |
Nurtec ODT® (rimegepant sulfate tablets) |
11,083,724 |
Pfizer Inc. v. Teva Pharms., Inc., 24-0627 (D. Del.) |
23-May-24 |
Hon. Colm F. Connolly |
Nurtec ODT® (rimegepant sulfate tablets) |
11,083,724 |
Esperion Therapeutics, Inc. v. MSN Pharms. Inc., 24-6386 (D.N.J.) |
23-May-24 |
Hon. Julien Xavier Neals |
Nexletol® (bempedoic acid tablets) |
11,760,714
11,613,511 |
Esperion Therapeutics, Inc. v. Sandoz Inc., 24-6387 (D.N.J.) |
23-May-24 |
Hon. Julien Xavier Neals |
Nexletol® (bempedoic acid tablets) Nexlizet® (bempedoic acid / ezetimibe tablets) |
11,926,584
11,760,714
11,613,511
10,912,751
11,744,816 |
Esperion Therapeutics, Inc. v. Hetero USA Inc., 24-6389 (D.N.J.) |
23-May-24 |
Hon. Julien Xavier Neals |
Nexletol® (bempedoic acid tablets) |
7,335,799
11,760,714
11,613,511 |
Esperion Therapeutics, Inc. v. Dr. Reddy’s Labs. Inc., 24-6391 (D.N.J.) |
23-May-24 |
Hon. Julien Xavier Neals |
Nexletol® (bempedoic acid tablets) Nexlizet® (bempedoic acid / ezetimibe tablets) |
7,335,799
11,760,714
11,613,511
10,912,751
11,744,816 |
GE Healthcare Ltd. v. Jubilant Draximage Inc., 24-6486 (D.N.J.) |
28-May-24 |
Hon. Madeline Cox Arleo |
Myoview™ (technetium Tc99m tetrofosmin for injection) |
9,549,999 |
Axsome Therapeutics, Inc. v. Teva Pharms., Inc., 24-6489 (D.N.J.) |
28-May-24 |
Hon. Michael E. Farbiarz |
Auvelity® (dextromethorphan hydrobromide / bupropion HCl extended-release tablets) |
11,839,612
11,844,797
11,883,373
11,896,563
11,925,636
11,969,421 |
Viiv Healthcare Co. v. Hetero USA, Inc., 24-0657 (D. Del.) |
3-Jun-24 |
Hon. Mitchell S. Goldberg |
Triumeq® (abacavir / dolutegravir / lamivudine tablets) |
9,242,986 |
AbbVie Inc. v. Qilu Pharma, Inc., 24-6759 (D.N.J.) |
6-Jun-24 |
Hon. Zahid N. Quraishi |
Avycaz® (ceftazidime / avibactam for injection) |
8,471,025
8,835,455
8,969,566
9,284,314
9,695,122 |
Eisai R&D Management Co., Ltd. v. Dr. Reddy’s Labs., Inc., 24-6765 (D.N.J.) |
6-Jun-24 |
Hon. Christine P. O'Hearn |
Lenvima® (lenvatinib mesylate capsules) |
7,612,208
10,407,393
11,186,547 |
Aragon Pharms., Inc. v. Hetero Labs Ltd. Unit V, 24-6784 (D.N.J.) |
6-Jun-24 |
Hon. Stanley R. Chesler |
Erleada® (apalutamide tablets) |
8,802,689
9,388,159
9,987,261 |
Vifor (Int’l) AG v. Dr. Reddy’s Labs., Ltd., 24-6833 (D.N.J.) |
7-Jun-24 |
Hon. Georgette Castner |
Injectafer® (ferric carboxymaltose injection) |
7,612,109
7,754,702
8,895,612
11,364,260
11,433,091
11,478,502 |
Amicus Therapeutics US, LLC v. Aurobindo Pharma Ltd., 24-0698 (D. Del.) |
13-Jun-24 |
Hon. Colm F. Connolly |
Galafold® (migalastat capsules) |
11,833,164 |
Amicus Therapeutics US, LLC v. Aurobindo Pharma Ltd., 24-0698 (D. Del.) |
13-Jun-24 |
Hon. Colm F. Connolly |
Galafold® (migalastat capsules) |
11,833,164 |
AbbVie Inc. v. Fresenius Kabi USA, LLC, 24-4914 (N.D. Ill.) |
13-Jun-24 |
Hon. John Robert Blakey |
Avycaz® (ceftazidime / avibactam for injection) |
8,471,025
8,835,455
8,969,566
9,284,314
9,695,122 |
Merck KGaA v. TWi Pharms., Inc., 24-0700 (D. Del.) |
14-Jun-24 |
Hon. Maryellen Noreika |
Mavenclad® (cladribine tablets) |
7,713,947
8,377,903 |
Eisai R&D Management Co., Ltd. v. Torrent Pharms. Ltd., 24-7067 (D.N.J.) |
17-Jun-24 |
Hon. Christine P. O’Hearn |
Lenvima® (lenvatinib mesylate capsules) |
7,612,208
10,407,393
11,186,547 |
SK Biopharms. Co., Ltd. v. Aurobindo Pharma Ltd., 24-0718 (D. Del.) |
18-Jun-24 |
Hon. Jennifer L. Hall |
Xcopri® (cenobamate tablets) |
7,598,279
11,654,133 |
Janssen Pharms., Inc. v. Qilu Pharm. Co., Ltd., 24-7094 (D.N.J.) |
18-Jun-24 |
Hon. Claire C. Cecchi |
Invega Sustenna® (paliperidone palmitate extended-release injectable suspension) |
9,439,906 |
Theravance Biopharma R&D IP, LLC v. Qilu Pharm. Co., Ltd., 24-2689 (E.D. Pa.) |
18-Jun-24 |
Hon. Kai N. Scott |
Yupelri® (revefenacin inhalation solution) |
8,541,451
9,765,028
10,550,081
11,008,289
11,484,531
11,691,948
11,858,898 |
Veloxis Pharms., Inc. v. Sun Pharm. Indus. Ltd., 24-0726 (D. Del.) |
19-Jun-24 |
Hon. Joshua D. Wolson |
Envarsus XR® (tacrolimus extended-release tablets) |
8,685,998
9,549,918
10,166,190
10,864,199
11,110,081
11,123,331
11,419,823 |
Exeltis USA, Inc. v. Lupin Ltd., 24-0732 (D. Del.) |
20-Jun-24 |
Hon. Richard G. Andrews |
Slynd® (drospirenone tablets) |
11,951,213 |
Salix Pharms., Inc. v. Norwich Pharms., Inc., 24-7140 (D.N.J.) |
20-Jun-24 |
Hon. Robert Kirsch |
Xifaxan® (rifaximin tablets) |
11,779,571
11,564,912 |
Otsuka Pharm. Co., Ltd. v. Sun Pharm. Indus. Ltd., 24-0740 (D. Del.) |
21-Jun-24 |
Hon. Richard G. Andrews |
Jynarque® (tolvaptan tablets) |
8,501,730
10,905,694
8,273,735 |
Teva Branded Pharm. Products R&D, Inc. v. Cipla USA, Inc., 24-7162 (D.N.J.) |
21-Jun-24 |
Hon. Stanley R. Chesler |
Qvar RediHaler® (beclomethasone dipropionate inhalation aerosol) |
11,957,832 |
Bausch Health Ireland Ltd. v. MSN Labs. Private Ltd., 24-7182 (D.N.J.) |
21-Jun-24 |
Hon. Stanley R. Chesler |
Trulance® (plecanatide tablets) |
11,834,521 |
Boehringer Ingelheim Pharms. Inc. v. Granules India Ltd., 24-0753 (D. Del.) |
25-Jun-24 |
Hon. Colm F. Connolly |
Tradjenta® (linagliptin tablets) |
9,486,526
10,034,877 |
Pfizer Inc. v. Biocon Ltd., 24-0757 (D. Del.) |
26-Jun-24 |
Hon. Colm F. Connolly |
Xeljanz® XR (tofacitinib citrate extended-release tablets) |
RE41,783 |
AstraZeneca Pharms. LP v. Cipla Ltd., 24-7346 (D.N.J.) |
28-Jun-24 |
Hon. Robert Kirsch |
Lynparza® (olaparib tablets) |
8,859,562
11,970,530
11,975,001
8,475,842
11,633,396 |